NextKidney BV acquires Dialyss Pte Ltd as of January 1st, 2022
Strengthening the development of the first portable haemodialysis device. NextKidney BV is proud to announce the acquisition of 100% of the share capital of Dialyss Pte Ltd as of January
Healthtech Accellerator infuses the mobility industry
As the leading healthtech Accellerator in the Nordics, with a focus on broadening the possible use of innovations across industries, we are very excited to announce that two of our
Injeq’s IQ-Tip needle received CE certification
The medical technology company Injeq’s development yielded the desired outcome after many years of efforts as the company’s IQ-Tip needle received CE approval on December 21, 2021. The needle can be
AlzeCure presents novel Alzstatin data at the 11th Symposium on Pharmaceutical Profiling meeting
AlzeCure Pharma AB (publ) (FN STO: ALZCUR), a pharmaceutical company that develops a broad portfolio of small molecule drug candidates for diseases affecting the central nervous system, with projects in
AstraZeneca and Ionis has closed an agreement to develop and commercialise eplontersen
AstraZeneca has closed a global development and commercialisation agreement with Ionis Pharmaceuticals, Inc. (Ionis) for eplontersen, formerly known as IONIS-TTR-LRX. The companies will jointly develop and commercialise eplontersen in the US, while
A model of GlobalData predicts future healthtech unicorns
Healthcare startups are constantly seeking to embrace emerging technologies to improve efficiency, increase customer engagement, and remain competitive. Against this backdrop, the Unicorn Prediction Model of GlobalData, a leading data
For IBS, specific diets are less important than they expected
Many IBS sufferers avoid certain types of food and often exclude gluten. However, a large new study from Chalmers University of Technology and Uppsala University, Sweden, does not show a
2cureX launches IndiTreat mCRC Start test
2cureX announced today the launch of the IndiTreat® mCRC Start test, to guide 1st line drug therapy in patients with metastatic colorectal cancer (mCRC). The test is the second in
Positive results from Sigrid Therapeutics proof-of-concept prediabetes STAR
First-in-Class Medical Device SiPore15® – based therapy significantly reduced long-term blood sugar levels and improved metabolic parameters in prediabetics. Sigrid Therapeutics AB, an innovative technology company developing a new class
Solve.Care launches Care.Labs, the New Development Portal that gives physicians and developers the power to change the world of healthcare
Solve.Care, the global healthcare blockchain technology company, announced today that they have launched their new development portal Care.Labs. Care.Labs will help to guide both physicians and developers in designing and